Legal & General Group PLC Adma Biologics, Inc. Transaction History

Legal & General Group PLC

  • $368 Billion
  • Q4 2024

A detailed history of Legal & General Group PLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 836,850 shares of ADMA stock, worth $15.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
836,850
Previous 697,010 20.06%
Holding current value
$15.4 Million
Previous $13.9 Million 3.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$15.62 - $22.62 $2.18 Million - $3.16 Million
139,840 Added 20.06%
836,850 $14.4 Million
Q3 2024

Feb 28, 2025
SELL
$11.21 - $20.03 $1.84 Million - $3.29 Million
-164,013 Reduced 19.6%
672,837 $13.5 Million
Q3 2024

Nov 14, 2024
BUY
$11.21 - $20.03 $4.92 Million - $8.78 Million
438,527 Added 169.65%
697,010 $13.9 Million
Q2 2024

Aug 14, 2024
BUY
$5.98 - $11.18 $209,760 - $392,160
35,077 Added 15.7%
258,483 $2.89 Million
Q1 2024

Jul 01, 2024
BUY
$4.4 - $6.74 $38,926 - $59,628
8,847 Added 4.12%
223,406 $1.47 Million
Q1 2024

May 14, 2024
BUY
$4.4 - $6.74 $145,983 - $223,619
33,178 Added 18.29%
214,559 $1.42 Million
Q4 2023

Feb 15, 2024
BUY
$3.08 - $4.52 $15,018 - $22,039
4,876 Added 2.76%
181,381 $819,000
Q3 2023

Nov 14, 2023
BUY
$3.47 - $4.61 $51,571 - $68,513
14,862 Added 9.19%
176,505 $631,000
Q2 2023

Aug 14, 2023
BUY
$3.12 - $4.22 $263,842 - $356,864
84,565 Added 109.71%
161,643 $596,000
Q1 2023

May 15, 2023
BUY
$3.01 - $3.87 $23,727 - $30,507
7,883 Added 11.39%
77,078 $255,000
Q4 2022

Feb 14, 2023
BUY
$2.47 - $3.88 $122,813 - $192,921
49,722 Added 255.34%
69,195 $268,000
Q3 2022

Nov 14, 2022
SELL
$2.03 - $2.86 $14,853 - $20,926
-7,317 Reduced 27.31%
19,473 $47,000
Q2 2022

Aug 22, 2022
BUY
$1.43 - $2.2 $38,309 - $58,938
26,790 New
26,790 $53,000
Q2 2021

Aug 12, 2021
SELL
$1.51 - $2.07 $10,665 - $14,620
-7,063 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$2.04 - $3.74 $6,929 - $12,704
-3,397 Reduced 32.48%
7,063 $17,000
Q1 2020

May 14, 2020
BUY
$1.5 - $4.59 $502 - $1,537
335 Added 3.31%
10,460 $30,000
Q4 2019

Feb 13, 2020
BUY
$3.89 - $5.15 $6,799 - $9,002
1,748 Added 20.87%
10,125 $41,000
Q3 2019

Nov 13, 2019
BUY
$3.19 - $5.39 $10,724 - $18,121
3,362 Added 67.04%
8,377 $37,000
Q2 2019

Aug 14, 2019
BUY
$3.52 - $5.24 $7,758 - $11,548
2,204 Added 78.41%
5,015 $19,000
Q2 2018

Aug 10, 2018
BUY
$4.39 - $5.44 $12,340 - $15,291
2,811 New
2,811 $13,000

Others Institutions Holding ADMA

# of Institutions
339
Shares Held
182M
Call Options Held
1.72M
Put Options Held
846K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.62B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email